DC
CLBT icon

Diametric Capital’s Cellebrite CLBT Stock Holding History

Diametric Capital’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
84,014
+43,094
+105% +$570K 0.13% 175
2026
Q1 		$564K Buy
40,920
+16,611
+68% +$250K 0.15% 178
2025
Q4 		$438K Buy
24,309
+13,797
+131% +$248K 0.12% 260
2025
Q3 		$195K Sell
10,512
-2,420
-19% -$38K 0.07% 336
2025
Q2 		$207K Buy
+12,932
New +$231K 0.11% 253
2023
Q1 		– Sell
-57,225
Closed -$250K – 367
2022
Q4 		$250K Buy
+57,225
New +$256K 0.12% 223
2022
Q1 		– Sell
-26,075
Closed -$209K – 270
2021
Q4 		$209K Buy
+26,075
New +$246K 0.16% 128

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Diametric Capital's CLBT Position: Q2 2026 in Review

Diametric Capital increased its Cellebrite (CLBT) stake by 105% in Q2 2026, buying an estimated $570K and bringing the position to 84,014 shares worth $1.23M. The position accounts for 0.13% of the portfolio, ranked #175.

Diametric Capital first reported a position in CLBT in Q4 2021 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Diametric Capital held 84,014 shares of Cellebrite worth $1.23M as of Q2 2026.
  • Diametric Capital bought 43,094 Cellebrite shares in Q2 2026, an estimated $570K.
  • Cellebrite made up 0.13% of Diametric Capital's portfolio in Q2 2026, its #175 holding.
  • Diametric Capital first reported a position in Cellebrite in Q4 2021 and has held it in 7 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.